Co-funding Institute(s):
National Institute of Child Health and Human Development (NICHD)
Outcome Measures for Clinical Trials in Children with Fragile X Syndrome – Part II
July 8, 2009 - July 9, 2009
Bethesda, MD, United States
DescriptionThe goals for the first meeting were to (1) Describe outcome measures for safety and efficacy when treating children with FXS (2) Assess validation of those measures for clinical studies (3) Describe approaches for preclinical toxicology studies to define efficacy and safety.
Contact for additional information: Dr. Sophia Wang, 301-402-5374
Additional Information:
|